Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Aspiration Biopsy Needle Market

ID: MRFR/MED/7478-HCR
100 Pages
Satyendra Maurya
Last Updated: April 06, 2026

Aspiration Biopsy Needle Market Research Report: Size, Share, Trend Analysis By Types (Spring-loaded Needles, Vacuum-assisted Needles, Stylet Needles), By Needle (Core Biopsy Needles, Fine Needle Aspiration Needles), By Indication (Lung Cancer, Kidney Cancer, Prostate Cancer, Breast Cancer), By End Users (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth Outlook & Industry Forecast 2025 To 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Aspiration Biopsy Needle Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Application (USD Million)
  49.     4.1.1 Cytology
  50.     4.1.2 Histology
  51.     4.1.3 Pathology
  52.     4.1.4 Oncology
  53.   4.2 Healthcare, BY End Use (USD Million)
  54.     4.2.1 Hospitals
  55.     4.2.2 Diagnostic Laboratories
  56.     4.2.3 Research Institutions
  57.     4.2.4 Ambulatory Surgical Centers
  58.   4.3 Healthcare, BY Needle Type (USD Million)
  59.     4.3.1 Fine Needle Aspiration Needle
  60.     4.3.2 Core Needle
  61.     4.3.3 Vacuum-Assisted Needle
  62.     4.3.4 Aspiration Biopsy Needle
  63.   4.4 Healthcare, BY Guidance Method (USD Million)
  64.     4.4.1 Ultrasound-Guided
  65.     4.4.2 CT-Guided
  66.     4.4.3 Fluoroscopy-Guided
  67.     4.4.4 Mammography-Guided
  68.   4.5 Healthcare, BY Material (USD Million)
  69.     4.5.1 Stainless Steel
  70.     4.5.2 Plastic
  71.     4.5.3 Silicone
  72.     4.5.4 Composite
  73.   4.6 Healthcare, BY Region (USD Million)
  74.     4.6.1 North America
  75.       4.6.1.1 US
  76.       4.6.1.2 Canada
  77.     4.6.2 Europe
  78.       4.6.2.1 Germany
  79.       4.6.2.2 UK
  80.       4.6.2.3 France
  81.       4.6.2.4 Russia
  82.       4.6.2.5 Italy
  83.       4.6.2.6 Spain
  84.       4.6.2.7 Rest of Europe
  85.     4.6.3 APAC
  86.       4.6.3.1 China
  87.       4.6.3.2 India
  88.       4.6.3.3 Japan
  89.       4.6.3.4 South Korea
  90.       4.6.3.5 Malaysia
  91.       4.6.3.6 Thailand
  92.       4.6.3.7 Indonesia
  93.       4.6.3.8 Rest of APAC
  94.     4.6.4 South America
  95.       4.6.4.1 Brazil
  96.       4.6.4.2 Mexico
  97.       4.6.4.3 Argentina
  98.       4.6.4.4 Rest of South America
  99.     4.6.5 MEA
  100.       4.6.5.1 GCC Countries
  101.       4.6.5.2 South Africa
  102.       4.6.5.3 Rest of MEA
  103. 5 SECTION V: COMPETITIVE ANALYSIS
  104.   5.1 Competitive Landscape
  105.     5.1.1 Overview
  106.     5.1.2 Competitive Analysis
  107.     5.1.3 Market share Analysis
  108.     5.1.4 Major Growth Strategy in the Healthcare
  109.     5.1.5 Competitive Benchmarking
  110.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  111.     5.1.7 Key developments and growth strategies
  112.       5.1.7.1 New Product Launch/Service Deployment
  113.       5.1.7.2 Merger & Acquisitions
  114.       5.1.7.3 Joint Ventures
  115.     5.1.8 Major Players Financial Matrix
  116.       5.1.8.1 Sales and Operating Income
  117.       5.1.8.2 Major Players R&D Expenditure. 2023
  118.   5.2 Company Profiles
  119.     5.2.1 Boston Scientific (US)
  120.       5.2.1.1 Financial Overview
  121.       5.2.1.2 Products Offered
  122.       5.2.1.3 Key Developments
  123.       5.2.1.4 SWOT Analysis
  124.       5.2.1.5 Key Strategies
  125.     5.2.2 Medtronic (US)
  126.       5.2.2.1 Financial Overview
  127.       5.2.2.2 Products Offered
  128.       5.2.2.3 Key Developments
  129.       5.2.2.4 SWOT Analysis
  130.       5.2.2.5 Key Strategies
  131.     5.2.3 Cook Medical (US)
  132.       5.2.3.1 Financial Overview
  133.       5.2.3.2 Products Offered
  134.       5.2.3.3 Key Developments
  135.       5.2.3.4 SWOT Analysis
  136.       5.2.3.5 Key Strategies
  137.     5.2.4 Becton Dickinson (US)
  138.       5.2.4.1 Financial Overview
  139.       5.2.4.2 Products Offered
  140.       5.2.4.3 Key Developments
  141.       5.2.4.4 SWOT Analysis
  142.       5.2.4.5 Key Strategies
  143.     5.2.5 Hologic (US)
  144.       5.2.5.1 Financial Overview
  145.       5.2.5.2 Products Offered
  146.       5.2.5.3 Key Developments
  147.       5.2.5.4 SWOT Analysis
  148.       5.2.5.5 Key Strategies
  149.     5.2.6 Terumo (JP)
  150.       5.2.6.1 Financial Overview
  151.       5.2.6.2 Products Offered
  152.       5.2.6.3 Key Developments
  153.       5.2.6.4 SWOT Analysis
  154.       5.2.6.5 Key Strategies
  155.     5.2.7 Smiths Medical (GB)
  156.       5.2.7.1 Financial Overview
  157.       5.2.7.2 Products Offered
  158.       5.2.7.3 Key Developments
  159.       5.2.7.4 SWOT Analysis
  160.       5.2.7.5 Key Strategies
  161.     5.2.8 Stryker (US)
  162.       5.2.8.1 Financial Overview
  163.       5.2.8.2 Products Offered
  164.       5.2.8.3 Key Developments
  165.       5.2.8.4 SWOT Analysis
  166.       5.2.8.5 Key Strategies
  167.     5.2.9 Olympus (JP)
  168.       5.2.9.1 Financial Overview
  169.       5.2.9.2 Products Offered
  170.       5.2.9.3 Key Developments
  171.       5.2.9.4 SWOT Analysis
  172.       5.2.9.5 Key Strategies
  173.   5.3 Appendix
  174.     5.3.1 References
  175.     5.3.2 Related Reports
  176. 6 LIST OF FIGURES
  177.   6.1 MARKET SYNOPSIS
  178.   6.2 NORTH AMERICA MARKET ANALYSIS
  179.   6.3 US MARKET ANALYSIS BY APPLICATION
  180.   6.4 US MARKET ANALYSIS BY END USE
  181.   6.5 US MARKET ANALYSIS BY NEEDLE TYPE
  182.   6.6 US MARKET ANALYSIS BY GUIDANCE METHOD
  183.   6.7 US MARKET ANALYSIS BY MATERIAL
  184.   6.8 CANADA MARKET ANALYSIS BY APPLICATION
  185.   6.9 CANADA MARKET ANALYSIS BY END USE
  186.   6.10 CANADA MARKET ANALYSIS BY NEEDLE TYPE
  187.   6.11 CANADA MARKET ANALYSIS BY GUIDANCE METHOD
  188.   6.12 CANADA MARKET ANALYSIS BY MATERIAL
  189.   6.13 EUROPE MARKET ANALYSIS
  190.   6.14 GERMANY MARKET ANALYSIS BY APPLICATION
  191.   6.15 GERMANY MARKET ANALYSIS BY END USE
  192.   6.16 GERMANY MARKET ANALYSIS BY NEEDLE TYPE
  193.   6.17 GERMANY MARKET ANALYSIS BY GUIDANCE METHOD
  194.   6.18 GERMANY MARKET ANALYSIS BY MATERIAL
  195.   6.19 UK MARKET ANALYSIS BY APPLICATION
  196.   6.20 UK MARKET ANALYSIS BY END USE
  197.   6.21 UK MARKET ANALYSIS BY NEEDLE TYPE
  198.   6.22 UK MARKET ANALYSIS BY GUIDANCE METHOD
  199.   6.23 UK MARKET ANALYSIS BY MATERIAL
  200.   6.24 FRANCE MARKET ANALYSIS BY APPLICATION
  201.   6.25 FRANCE MARKET ANALYSIS BY END USE
  202.   6.26 FRANCE MARKET ANALYSIS BY NEEDLE TYPE
  203.   6.27 FRANCE MARKET ANALYSIS BY GUIDANCE METHOD
  204.   6.28 FRANCE MARKET ANALYSIS BY MATERIAL
  205.   6.29 RUSSIA MARKET ANALYSIS BY APPLICATION
  206.   6.30 RUSSIA MARKET ANALYSIS BY END USE
  207.   6.31 RUSSIA MARKET ANALYSIS BY NEEDLE TYPE
  208.   6.32 RUSSIA MARKET ANALYSIS BY GUIDANCE METHOD
  209.   6.33 RUSSIA MARKET ANALYSIS BY MATERIAL
  210.   6.34 ITALY MARKET ANALYSIS BY APPLICATION
  211.   6.35 ITALY MARKET ANALYSIS BY END USE
  212.   6.36 ITALY MARKET ANALYSIS BY NEEDLE TYPE
  213.   6.37 ITALY MARKET ANALYSIS BY GUIDANCE METHOD
  214.   6.38 ITALY MARKET ANALYSIS BY MATERIAL
  215.   6.39 SPAIN MARKET ANALYSIS BY APPLICATION
  216.   6.40 SPAIN MARKET ANALYSIS BY END USE
  217.   6.41 SPAIN MARKET ANALYSIS BY NEEDLE TYPE
  218.   6.42 SPAIN MARKET ANALYSIS BY GUIDANCE METHOD
  219.   6.43 SPAIN MARKET ANALYSIS BY MATERIAL
  220.   6.44 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
  221.   6.45 REST OF EUROPE MARKET ANALYSIS BY END USE
  222.   6.46 REST OF EUROPE MARKET ANALYSIS BY NEEDLE TYPE
  223.   6.47 REST OF EUROPE MARKET ANALYSIS BY GUIDANCE METHOD
  224.   6.48 REST OF EUROPE MARKET ANALYSIS BY MATERIAL
  225.   6.49 APAC MARKET ANALYSIS
  226.   6.50 CHINA MARKET ANALYSIS BY APPLICATION
  227.   6.51 CHINA MARKET ANALYSIS BY END USE
  228.   6.52 CHINA MARKET ANALYSIS BY NEEDLE TYPE
  229.   6.53 CHINA MARKET ANALYSIS BY GUIDANCE METHOD
  230.   6.54 CHINA MARKET ANALYSIS BY MATERIAL
  231.   6.55 INDIA MARKET ANALYSIS BY APPLICATION
  232.   6.56 INDIA MARKET ANALYSIS BY END USE
  233.   6.57 INDIA MARKET ANALYSIS BY NEEDLE TYPE
  234.   6.58 INDIA MARKET ANALYSIS BY GUIDANCE METHOD
  235.   6.59 INDIA MARKET ANALYSIS BY MATERIAL
  236.   6.60 JAPAN MARKET ANALYSIS BY APPLICATION
  237.   6.61 JAPAN MARKET ANALYSIS BY END USE
  238.   6.62 JAPAN MARKET ANALYSIS BY NEEDLE TYPE
  239.   6.63 JAPAN MARKET ANALYSIS BY GUIDANCE METHOD
  240.   6.64 JAPAN MARKET ANALYSIS BY MATERIAL
  241.   6.65 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
  242.   6.66 SOUTH KOREA MARKET ANALYSIS BY END USE
  243.   6.67 SOUTH KOREA MARKET ANALYSIS BY NEEDLE TYPE
  244.   6.68 SOUTH KOREA MARKET ANALYSIS BY GUIDANCE METHOD
  245.   6.69 SOUTH KOREA MARKET ANALYSIS BY MATERIAL
  246.   6.70 MALAYSIA MARKET ANALYSIS BY APPLICATION
  247.   6.71 MALAYSIA MARKET ANALYSIS BY END USE
  248.   6.72 MALAYSIA MARKET ANALYSIS BY NEEDLE TYPE
  249.   6.73 MALAYSIA MARKET ANALYSIS BY GUIDANCE METHOD
  250.   6.74 MALAYSIA MARKET ANALYSIS BY MATERIAL
  251.   6.75 THAILAND MARKET ANALYSIS BY APPLICATION
  252.   6.76 THAILAND MARKET ANALYSIS BY END USE
  253.   6.77 THAILAND MARKET ANALYSIS BY NEEDLE TYPE
  254.   6.78 THAILAND MARKET ANALYSIS BY GUIDANCE METHOD
  255.   6.79 THAILAND MARKET ANALYSIS BY MATERIAL
  256.   6.80 INDONESIA MARKET ANALYSIS BY APPLICATION
  257.   6.81 INDONESIA MARKET ANALYSIS BY END USE
  258.   6.82 INDONESIA MARKET ANALYSIS BY NEEDLE TYPE
  259.   6.83 INDONESIA MARKET ANALYSIS BY GUIDANCE METHOD
  260.   6.84 INDONESIA MARKET ANALYSIS BY MATERIAL
  261.   6.85 REST OF APAC MARKET ANALYSIS BY APPLICATION
  262.   6.86 REST OF APAC MARKET ANALYSIS BY END USE
  263.   6.87 REST OF APAC MARKET ANALYSIS BY NEEDLE TYPE
  264.   6.88 REST OF APAC MARKET ANALYSIS BY GUIDANCE METHOD
  265.   6.89 REST OF APAC MARKET ANALYSIS BY MATERIAL
  266.   6.90 SOUTH AMERICA MARKET ANALYSIS
  267.   6.91 BRAZIL MARKET ANALYSIS BY APPLICATION
  268.   6.92 BRAZIL MARKET ANALYSIS BY END USE
  269.   6.93 BRAZIL MARKET ANALYSIS BY NEEDLE TYPE
  270.   6.94 BRAZIL MARKET ANALYSIS BY GUIDANCE METHOD
  271.   6.95 BRAZIL MARKET ANALYSIS BY MATERIAL
  272.   6.96 MEXICO MARKET ANALYSIS BY APPLICATION
  273.   6.97 MEXICO MARKET ANALYSIS BY END USE
  274.   6.98 MEXICO MARKET ANALYSIS BY NEEDLE TYPE
  275.   6.99 MEXICO MARKET ANALYSIS BY GUIDANCE METHOD
  276.   6.100 MEXICO MARKET ANALYSIS BY MATERIAL
  277.   6.101 ARGENTINA MARKET ANALYSIS BY APPLICATION
  278.   6.102 ARGENTINA MARKET ANALYSIS BY END USE
  279.   6.103 ARGENTINA MARKET ANALYSIS BY NEEDLE TYPE
  280.   6.104 ARGENTINA MARKET ANALYSIS BY GUIDANCE METHOD
  281.   6.105 ARGENTINA MARKET ANALYSIS BY MATERIAL
  282.   6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
  283.   6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
  284.   6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY NEEDLE TYPE
  285.   6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY GUIDANCE METHOD
  286.   6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY MATERIAL
  287.   6.111 MEA MARKET ANALYSIS
  288.   6.112 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
  289.   6.113 GCC COUNTRIES MARKET ANALYSIS BY END USE
  290.   6.114 GCC COUNTRIES MARKET ANALYSIS BY NEEDLE TYPE
  291.   6.115 GCC COUNTRIES MARKET ANALYSIS BY GUIDANCE METHOD
  292.   6.116 GCC COUNTRIES MARKET ANALYSIS BY MATERIAL
  293.   6.117 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
  294.   6.118 SOUTH AFRICA MARKET ANALYSIS BY END USE
  295.   6.119 SOUTH AFRICA MARKET ANALYSIS BY NEEDLE TYPE
  296.   6.120 SOUTH AFRICA MARKET ANALYSIS BY GUIDANCE METHOD
  297.   6.121 SOUTH AFRICA MARKET ANALYSIS BY MATERIAL
  298.   6.122 REST OF MEA MARKET ANALYSIS BY APPLICATION
  299.   6.123 REST OF MEA MARKET ANALYSIS BY END USE
  300.   6.124 REST OF MEA MARKET ANALYSIS BY NEEDLE TYPE
  301.   6.125 REST OF MEA MARKET ANALYSIS BY GUIDANCE METHOD
  302.   6.126 REST OF MEA MARKET ANALYSIS BY MATERIAL
  303.   6.127 KEY BUYING CRITERIA OF HEALTHCARE
  304.   6.128 RESEARCH PROCESS OF MRFR
  305.   6.129 DRO ANALYSIS OF HEALTHCARE
  306.   6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  307.   6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  308.   6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
  309.   6.133 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
  310.   6.134 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
  311.   6.135 HEALTHCARE, BY END USE, 2024 (% SHARE)
  312.   6.136 HEALTHCARE, BY END USE, 2024 TO 2035 (USD Million)
  313.   6.137 HEALTHCARE, BY NEEDLE TYPE, 2024 (% SHARE)
  314.   6.138 HEALTHCARE, BY NEEDLE TYPE, 2024 TO 2035 (USD Million)
  315.   6.139 HEALTHCARE, BY GUIDANCE METHOD, 2024 (% SHARE)
  316.   6.140 HEALTHCARE, BY GUIDANCE METHOD, 2024 TO 2035 (USD Million)
  317.   6.141 HEALTHCARE, BY MATERIAL, 2024 (% SHARE)
  318.   6.142 HEALTHCARE, BY MATERIAL, 2024 TO 2035 (USD Million)
  319.   6.143 BENCHMARKING OF MAJOR COMPETITORS
  320. 7 LIST OF TABLES
  321.   7.1 LIST OF ASSUMPTIONS
  322.     7.1.1
  323.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  324.     7.2.1 BY APPLICATION, 2025-2035 (USD Million)
  325.     7.2.2 BY END USE, 2025-2035 (USD Million)
  326.     7.2.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  327.     7.2.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  328.     7.2.5 BY MATERIAL, 2025-2035 (USD Million)
  329.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  330.     7.3.1 BY APPLICATION, 2025-2035 (USD Million)
  331.     7.3.2 BY END USE, 2025-2035 (USD Million)
  332.     7.3.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  333.     7.3.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  334.     7.3.5 BY MATERIAL, 2025-2035 (USD Million)
  335.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  336.     7.4.1 BY APPLICATION, 2025-2035 (USD Million)
  337.     7.4.2 BY END USE, 2025-2035 (USD Million)
  338.     7.4.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  339.     7.4.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  340.     7.4.5 BY MATERIAL, 2025-2035 (USD Million)
  341.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  342.     7.5.1 BY APPLICATION, 2025-2035 (USD Million)
  343.     7.5.2 BY END USE, 2025-2035 (USD Million)
  344.     7.5.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  345.     7.5.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  346.     7.5.5 BY MATERIAL, 2025-2035 (USD Million)
  347.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  348.     7.6.1 BY APPLICATION, 2025-2035 (USD Million)
  349.     7.6.2 BY END USE, 2025-2035 (USD Million)
  350.     7.6.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  351.     7.6.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  352.     7.6.5 BY MATERIAL, 2025-2035 (USD Million)
  353.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  354.     7.7.1 BY APPLICATION, 2025-2035 (USD Million)
  355.     7.7.2 BY END USE, 2025-2035 (USD Million)
  356.     7.7.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  357.     7.7.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  358.     7.7.5 BY MATERIAL, 2025-2035 (USD Million)
  359.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  360.     7.8.1 BY APPLICATION, 2025-2035 (USD Million)
  361.     7.8.2 BY END USE, 2025-2035 (USD Million)
  362.     7.8.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  363.     7.8.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  364.     7.8.5 BY MATERIAL, 2025-2035 (USD Million)
  365.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  366.     7.9.1 BY APPLICATION, 2025-2035 (USD Million)
  367.     7.9.2 BY END USE, 2025-2035 (USD Million)
  368.     7.9.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  369.     7.9.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  370.     7.9.5 BY MATERIAL, 2025-2035 (USD Million)
  371.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  372.     7.10.1 BY APPLICATION, 2025-2035 (USD Million)
  373.     7.10.2 BY END USE, 2025-2035 (USD Million)
  374.     7.10.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  375.     7.10.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  376.     7.10.5 BY MATERIAL, 2025-2035 (USD Million)
  377.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  378.     7.11.1 BY APPLICATION, 2025-2035 (USD Million)
  379.     7.11.2 BY END USE, 2025-2035 (USD Million)
  380.     7.11.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  381.     7.11.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  382.     7.11.5 BY MATERIAL, 2025-2035 (USD Million)
  383.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  384.     7.12.1 BY APPLICATION, 2025-2035 (USD Million)
  385.     7.12.2 BY END USE, 2025-2035 (USD Million)
  386.     7.12.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  387.     7.12.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  388.     7.12.5 BY MATERIAL, 2025-2035 (USD Million)
  389.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  390.     7.13.1 BY APPLICATION, 2025-2035 (USD Million)
  391.     7.13.2 BY END USE, 2025-2035 (USD Million)
  392.     7.13.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  393.     7.13.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  394.     7.13.5 BY MATERIAL, 2025-2035 (USD Million)
  395.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  396.     7.14.1 BY APPLICATION, 2025-2035 (USD Million)
  397.     7.14.2 BY END USE, 2025-2035 (USD Million)
  398.     7.14.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  399.     7.14.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  400.     7.14.5 BY MATERIAL, 2025-2035 (USD Million)
  401.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  402.     7.15.1 BY APPLICATION, 2025-2035 (USD Million)
  403.     7.15.2 BY END USE, 2025-2035 (USD Million)
  404.     7.15.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  405.     7.15.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  406.     7.15.5 BY MATERIAL, 2025-2035 (USD Million)
  407.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  408.     7.16.1 BY APPLICATION, 2025-2035 (USD Million)
  409.     7.16.2 BY END USE, 2025-2035 (USD Million)
  410.     7.16.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  411.     7.16.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  412.     7.16.5 BY MATERIAL, 2025-2035 (USD Million)
  413.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  414.     7.17.1 BY APPLICATION, 2025-2035 (USD Million)
  415.     7.17.2 BY END USE, 2025-2035 (USD Million)
  416.     7.17.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  417.     7.17.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  418.     7.17.5 BY MATERIAL, 2025-2035 (USD Million)
  419.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  420.     7.18.1 BY APPLICATION, 2025-2035 (USD Million)
  421.     7.18.2 BY END USE, 2025-2035 (USD Million)
  422.     7.18.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  423.     7.18.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  424.     7.18.5 BY MATERIAL, 2025-2035 (USD Million)
  425.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  426.     7.19.1 BY APPLICATION, 2025-2035 (USD Million)
  427.     7.19.2 BY END USE, 2025-2035 (USD Million)
  428.     7.19.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  429.     7.19.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  430.     7.19.5 BY MATERIAL, 2025-2035 (USD Million)
  431.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  432.     7.20.1 BY APPLICATION, 2025-2035 (USD Million)
  433.     7.20.2 BY END USE, 2025-2035 (USD Million)
  434.     7.20.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  435.     7.20.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  436.     7.20.5 BY MATERIAL, 2025-2035 (USD Million)
  437.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  438.     7.21.1 BY APPLICATION, 2025-2035 (USD Million)
  439.     7.21.2 BY END USE, 2025-2035 (USD Million)
  440.     7.21.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  441.     7.21.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  442.     7.21.5 BY MATERIAL, 2025-2035 (USD Million)
  443.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  444.     7.22.1 BY APPLICATION, 2025-2035 (USD Million)
  445.     7.22.2 BY END USE, 2025-2035 (USD Million)
  446.     7.22.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  447.     7.22.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  448.     7.22.5 BY MATERIAL, 2025-2035 (USD Million)
  449.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  450.     7.23.1 BY APPLICATION, 2025-2035 (USD Million)
  451.     7.23.2 BY END USE, 2025-2035 (USD Million)
  452.     7.23.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  453.     7.23.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  454.     7.23.5 BY MATERIAL, 2025-2035 (USD Million)
  455.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  456.     7.24.1 BY APPLICATION, 2025-2035 (USD Million)
  457.     7.24.2 BY END USE, 2025-2035 (USD Million)
  458.     7.24.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  459.     7.24.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  460.     7.24.5 BY MATERIAL, 2025-2035 (USD Million)
  461.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  462.     7.25.1 BY APPLICATION, 2025-2035 (USD Million)
  463.     7.25.2 BY END USE, 2025-2035 (USD Million)
  464.     7.25.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  465.     7.25.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  466.     7.25.5 BY MATERIAL, 2025-2035 (USD Million)
  467.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  468.     7.26.1 BY APPLICATION, 2025-2035 (USD Million)
  469.     7.26.2 BY END USE, 2025-2035 (USD Million)
  470.     7.26.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  471.     7.26.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  472.     7.26.5 BY MATERIAL, 2025-2035 (USD Million)
  473.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  474.     7.27.1 BY APPLICATION, 2025-2035 (USD Million)
  475.     7.27.2 BY END USE, 2025-2035 (USD Million)
  476.     7.27.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  477.     7.27.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  478.     7.27.5 BY MATERIAL, 2025-2035 (USD Million)
  479.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  480.     7.28.1 BY APPLICATION, 2025-2035 (USD Million)
  481.     7.28.2 BY END USE, 2025-2035 (USD Million)
  482.     7.28.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  483.     7.28.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  484.     7.28.5 BY MATERIAL, 2025-2035 (USD Million)
  485.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  486.     7.29.1 BY APPLICATION, 2025-2035 (USD Million)
  487.     7.29.2 BY END USE, 2025-2035 (USD Million)
  488.     7.29.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  489.     7.29.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  490.     7.29.5 BY MATERIAL, 2025-2035 (USD Million)
  491.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  492.     7.30.1 BY APPLICATION, 2025-2035 (USD Million)
  493.     7.30.2 BY END USE, 2025-2035 (USD Million)
  494.     7.30.3 BY NEEDLE TYPE, 2025-2035 (USD Million)
  495.     7.30.4 BY GUIDANCE METHOD, 2025-2035 (USD Million)
  496.     7.30.5 BY MATERIAL, 2025-2035 (USD Million)
  497.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  498.     7.31.1
  499.   7.32 ACQUISITION/PARTNERSHIP
  500.     7.32.1

Healthcare Market Segmentation

Healthcare By Application (USD Million, 2025-2035)

  • Cytology
  • Histology
  • Pathology
  • Oncology

Healthcare By End Use (USD Million, 2025-2035)

  • Hospitals
  • Diagnostic Laboratories
  • Research Institutions
  • Ambulatory Surgical Centers

Healthcare By Needle Type (USD Million, 2025-2035)

  • Fine Needle Aspiration Needle
  • Core Needle
  • Vacuum-Assisted Needle
  • Aspiration Biopsy Needle

Healthcare By Guidance Method (USD Million, 2025-2035)

  • Ultrasound-Guided
  • CT-Guided
  • Fluoroscopy-Guided
  • Mammography-Guided

Healthcare By Material (USD Million, 2025-2035)

  • Stainless Steel
  • Plastic
  • Silicone
  • Composite

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions